Unicycive Therapeutics, Inc.
UNCY
$0.55
-$0.0721-11.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 169.48% | 125.49% | 122.02% | 101.09% | 2,032.09% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 14.65% | 32.89% | -39.83% | 46.31% | 66.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 188.92% | 0.73% | 85.63% | 57.68% | 104.40% |
| Total Current Assets | 130.97% | 103.25% | 100.88% | 97.36% | 406.77% |
|
|
|||||
| Total Current Assets | 130.97% | 103.25% | 100.88% | 97.36% | 406.77% |
| Net Property, Plant & Equipment | -9.09% | -4.58% | -32.11% | -30.35% | 355.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 123.16% | 98.41% | 95.35% | 92.58% | 403.58% |
|
|
|||||
| Total Accounts Payable | 26.10% | -49.45% | 192.64% | 56.96% | -5.94% |
| Total Accrued Expenses | 10.14% | 18.26% | 84.84% | 109.07% | 44.57% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 72.48% | 72.61% | 18.81% | 24.28% | 110.97% |
| Total Finance Division Other Current Liabilities | 44.18% | -44.68% | -37.08% | 90.44% | -- |
| Total Other Current Liabilities | 44.18% | -44.68% | -37.08% | 90.44% | -- |
| Total Current Liabilities | 37.56% | -32.33% | -15.13% | 89.62% | 433.92% |
|
|
|||||
| Total Current Liabilities | 37.56% | -32.33% | -15.13% | 89.62% | 433.92% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -74.89% | -51.99% | -56.78% | -47.97% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 34.65% | -33.01% | -16.78% | 83.72% | 448.11% |
|
|
|||||
| Common Stock & APIC | 78.98% | 78.93% | 84.04% | 82.29% | 81.12% |
| Retained Earnings | -56.91% | -40.54% | -44.34% | -76.04% | -89.84% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 295.09% | 721.53% | 23.36% | -62.15% | -717.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 76.27% | 80.43% | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | 76.27% | 80.43% | -- |
|
|
|||||
| Total Common Equity | 295.09% | 721.53% | 23.36% | -62.15% | -717.38% |
| Total Preferred Equity | -- | -- | 76.27% | 80.43% | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 295.09% | 711.01% | 358.87% | 106.63% | -717.38% |
|
|
|||||